ECSP045271A - Derivados de quinolina - Google Patents

Derivados de quinolina

Info

Publication number
ECSP045271A
ECSP045271A EC2004005271A ECSP045271A ECSP045271A EC SP045271 A ECSP045271 A EC SP045271A EC 2004005271 A EC2004005271 A EC 2004005271A EC SP045271 A ECSP045271 A EC SP045271A EC SP045271 A ECSP045271 A EC SP045271A
Authority
EC
Ecuador
Prior art keywords
quinoline derivatives
pharmaceuticals
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
EC2004005271A
Other languages
English (en)
Inventor
Peter Gull
Esteban Pombo-Villar
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP045271A publication Critical patent/ECSP045271A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere a novedosos derivados de benzo[g]quinolina, a su preparación, a su uso como productos farmacéuticos, y a composiciones farmacéuticas que los contienen.
EC2004005271A 2002-03-07 2004-09-02 Derivados de quinolina ECSP045271A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02005115 2002-03-07
EP02005117 2002-03-07

Publications (1)

Publication Number Publication Date
ECSP045271A true ECSP045271A (es) 2004-10-26

Family

ID=27790094

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005271A ECSP045271A (es) 2002-03-07 2004-09-02 Derivados de quinolina

Country Status (29)

Country Link
US (2) US7399768B2 (es)
EP (1) EP1480970B1 (es)
JP (2) JP2005519117A (es)
KR (1) KR101027977B1 (es)
CN (2) CN1293070C (es)
AR (1) AR038730A1 (es)
AU (1) AU2003219023B2 (es)
BR (1) BR0308201A (es)
CA (2) CA2706618A1 (es)
CO (1) CO5611196A2 (es)
CY (1) CY1106409T1 (es)
DE (1) DE60311233T2 (es)
DK (1) DK1480970T3 (es)
EC (1) ECSP045271A (es)
EG (1) EG24415A (es)
ES (1) ES2279100T3 (es)
HK (1) HK1071364A1 (es)
IL (1) IL163769A0 (es)
MX (1) MXPA04008666A (es)
MY (1) MY134325A (es)
NO (1) NO20044117L (es)
NZ (1) NZ534732A (es)
PE (1) PE20030927A1 (es)
PL (2) PL215012B1 (es)
PT (1) PT1480970E (es)
RU (1) RU2345991C2 (es)
SI (1) SI1480970T1 (es)
TW (1) TW200406401A (es)
WO (1) WO2003074511A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757601B1 (en) * 2002-03-07 2009-08-05 Novartis AG Quinoline derivatives and their use in glaucoma and myopia
MA50800A (fr) 2017-11-24 2020-09-30 H Lundbeck As Nouveaux promédicaments de catécholamine destinés à être utilisés dans le traitement de la maladie de parkinson
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA

Also Published As

Publication number Publication date
DK1480970T3 (da) 2007-03-05
TW200406401A (en) 2004-05-01
IL163769A0 (en) 2005-12-18
MXPA04008666A (es) 2004-12-06
HK1071364A1 (en) 2005-07-15
SI1480970T1 (sl) 2007-06-30
CY1106409T1 (el) 2011-10-12
PL370915A1 (en) 2005-06-13
AR038730A1 (es) 2005-01-26
PE20030927A1 (es) 2003-12-26
JP2005519117A (ja) 2005-06-30
PT1480970E (pt) 2007-03-30
CA2706618A1 (en) 2003-09-12
KR20040089615A (ko) 2004-10-21
RU2004129767A (ru) 2005-06-27
CA2477720A1 (en) 2003-09-12
CN1293070C (zh) 2007-01-03
PL215012B1 (pl) 2013-10-31
EG24415A (en) 2009-05-25
PL394208A1 (pl) 2011-08-16
DE60311233T2 (de) 2007-11-15
EP1480970B1 (en) 2007-01-17
RU2345991C2 (ru) 2009-02-10
AU2003219023A1 (en) 2003-09-16
US20050234085A1 (en) 2005-10-20
US7399768B2 (en) 2008-07-15
US20080255176A1 (en) 2008-10-16
CO5611196A2 (es) 2006-02-28
EP1480970A1 (en) 2004-12-01
AU2003219023B2 (en) 2006-11-30
KR101027977B1 (ko) 2011-04-13
CA2477720C (en) 2010-09-21
CN1639148A (zh) 2005-07-13
MY134325A (en) 2007-12-31
NZ534732A (en) 2006-05-26
NO20044117L (no) 2004-09-28
CN1939915A (zh) 2007-04-04
ES2279100T3 (es) 2007-08-16
DE60311233D1 (de) 2007-03-08
JP2010095550A (ja) 2010-04-30
WO2003074511A1 (en) 2003-09-12
PL210336B1 (pl) 2012-01-31
BR0308201A (pt) 2005-01-04

Similar Documents

Publication Publication Date Title
HN2002000300A (es) Nuevos derivados de piperazina
ECSP077271A (es) Derivados de pirimidina
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
ECSP077259A (es) Derivados de pirimidina
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
UY27098A1 (es) Derivados de indol
DOP2000000109A (es) Derivados de tiazolilamida
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2'flúor-2'-desoxitetra-hidrouridinas
CR9602A (es) Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
CU23415B7 (es) Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
UY29896A1 (es) Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
ES2178055T3 (es) Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BRPI0509067A (pt) formulações de matriz oral que compreendem licarbazepina
HN2001000235A (es) Derivados puentes de piperazina
ECSP034754A (es) Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
UY29308A1 (es) Derivado de quinolina, su uso, preparación y medicamento que lo contiene
ECSP045271A (es) Derivados de quinolina
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
UY26517A1 (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmacéuticas que las contienen, su uso como productos medicinales y procesos para prepararlas